This delivery order for $45,000 was awarded by the Department of the Army Medical Command to Inseonmedics Inc. for the second delivery of VENTANA HE600 reagents under Option Period I of an indefinite-delivery/indefinite-quantity contract vehicle. The reagents will support the Biological Defense Automated Analytical Platform located in South Korea. Performance will take place in South Korea and be completed by September 30, 2021. No set-aside designation was applied to this award to supply...
This is a firm-fixed-price delivery order contract awarded by the Defense Health Agency to Inseonmedics Inc., a for-profit corporation registered in SAM.gov. The contract, valued at $12,597.00, is for the supply of VENTANA HE600 reagents to support the Brian D. Allgood Army Community Hospital and Biological Defense Automated Analytical Platform in South Korea from October 1, 2023, through September 30, 2024. This delivery order is part of a larger indefinite delivery contract (IDV) with a...
This is a firm fixed price delivery order contract awarded by the U.S. Department of the Army Medical Command (MEDCOM) to Synyoung Biomedics, a South Korean for-profit company. The contract has a ceiling value of $88,417.00 and is for the delivery of reagents for arterial blood gas analyzers to support the Brian D. Allgood Army Community Hospital in South Korea. This delivery order was issued against a larger, single award indefinite delivery contract with a potential value of $421,130.00 that...
The U.S. Defense Health Agency awarded a firm fixed price delivery order contract to Synyoung Biomedics, a for-profit organization located in South Korea, to provide blood gas analyzers, reagents, and related diagnostic equipment. The contract has a ceiling value of $66,316 and a period of performance through September 30, 2025. This is the latest in a series of delivery order contracts Synyoung Biomedics has received from the Defense Health Agency and Department of the Army Medical Command to...
This is a $112,650.00 firm-fixed-price purchase order awarded by the Defense Health Agency to Nanoentek America, Inc., a Korea-based manufacturer of biotechnology research equipment and medical devices. The contract is for the provision of an AD1K-050 Consumable Kit for Blood Testing, with a performance period through January 13, 2030. The contract does not have a set-aside designation. Nanoentek America, Inc. is a for-profit, foreign-owned corporate entity that specializes in supplying advanced...
This is a firm fixed-price delivery order contract awarded by the U.S. Army Medical Command (MEDCOM) to Ortho-Clinical Diagnostics Singapore Pte. LTD. Korea Branch, a for-profit medical equipment manufacturer and supplier. The $312,341.00 contract is for the provision of reagents, chemistry/immunology equipment, and related services to support the VITROS XT 7600 System and VITROS 500 diagnostic systems at U.S. military medical facilities in South Korea. This order is part of a larger...
<p>Synyoung Biomedics was awarded a $71,238 firm fixed price delivery order contract by the Defense Health Agency to provide radiometer blood gas analyzer reagents for use in South Korea. The contract has a completion date of September 30, 2023 and was awarded on October 1, 2022 without a set-aside designation. The reagents will support medical diagnostic operations conducted by the Defense Health Agency in the Republic of Korea.</p>
The Department of the Army Medical Command awarded a $7,770.31 firm fixed-price blanket purchase agreement (BPA) call to Knrc Central Blood Center of South Korea for the period of April 1 to June 30, 2020. The BPA call was not associated with any set-aside designation and was issued under an existing BPA with the Medical Command to provide unspecified products or services. As the Army's medical treatment facility for service members stationed in South Korea, this award was likely issued to...
This is a firm fixed-price delivery order contract awarded by the Defense Health Agency (DHA) to Namu Med, a for-profit sole proprietorship based in South Korea. The contract, valued at $41,666.86, is for the provision of reagents for biochemical antibiotics susceptibility testing to support U.S. military medical facilities in South Korea, primarily the Brian Allgood Army Community Hospital, for the period of October 1, 2023, to September 30, 2024. Namu Med has an existing Indefinite Delivery...
The Department of the Army Medical Command awarded a firm fixed-price blanket purchase agreement (BPA) call contract valued at four thousand five hundred ninety dollars and ninety cents ($4,590.90) to Knrc Central Blood Center of South Korea. The contract period of performance is from August 1, 2019 through September 30, 2019 to support the agency's medical programs in South Korea. No set-aside designation was applied to this award made under an existing BPA vehicle to procure unspecified...